91892-56-7 Usage
Uses
Used in Pharmaceutical Industry:
[1,2,4]Triazolo[1,5-a][1,3,5]triazine-5,7-diamine, N,N,N',N'-tetramethyl-2-(3-nitrophenyl)is used as a potential pharmaceutical candidate for various applications due to its unique structural features and potential biological activities. Its aromatic and basic properties may allow it to interact with biological targets, making it a promising compound for the development of new drugs.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, [1,2,4]Triazolo[1,5-a][1,3,5]triazine-5,7-diamine, N,N,N',N'-tetramethyl-2-(3-nitrophenyl)is used as a subject of interest for further research and development. Its unique structural features and potential biological activities make it a valuable compound for exploring new therapeutic approaches and understanding the underlying mechanisms of various diseases.
Used in Drug Design and Development:
[1,2,4]Triazolo[1,5-a][1,3,5]triazine-5,7-diamine, N,N,N',N'-tetramethyl-2-(3-nitrophenyl)is used as a starting point for drug design and development. Its aromatic and basic properties, along with its unique structural features, make it a suitable candidate for the development of new drugs with improved efficacy, selectivity, and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 91892-56-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,8,9 and 2 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 91892-56:
(7*9)+(6*1)+(5*8)+(4*9)+(3*2)+(2*5)+(1*6)=167
167 % 10 = 7
So 91892-56-7 is a valid CAS Registry Number.
91892-56-7Relevant academic research and scientific papers
Triazines and Related Products. Part 26. Synthesis and Chemistry of Bicyclic Analogues of the Antitumour Drug 2,4,6-Tris(dimethylamino)-1,3,5-triazine (Hexamethylmelamine)
Langdon, Simon P.,Simmonds, Richard J.,Stevens, Malcolm F. G.
, p. 993 - 998 (2007/10/02)
Interaction of 2,4-bis(dimethylamino)-6-hydrazino-1,3,5-triazine (1c) with aryl aldehydes yields a series of aryl hydrazones (4) which cyclise to 3-aryl-5,7-bis(dimethylamino)-1,2,4-triazolotriazines (6) with lead(VI) acetate in dichloromethane.Rearrangement of these bicycles in methanolic sodium hydroxide affords stable isomeric 2-aryl-5,7-bis(dimethylamino)triazolotriazines (7).Selected examples from both series of triazolotriazines were screened against the mouse M5076 reticulum cell sarcoma and P388 leukaemia in vivo but proved to have no antitumour activity.
